Gallbladder and Biliary Disease Perspective

 
 
  • Drug Safety Warnings and Updates: January-March 2018 Don't miss these important summaries of safety labeling changes and boxed warnings by the FDA for the first quarter of 2018.
  • NAFLD Is a Growing Problem Recent guidance from the American Association for the Study of Liver Diseases for the evaluation and management of patients with nonalcoholic fatty liver disease is profiled.
  • Teen Surgery and Persistent Opioid Use Should we be more cautious about prescribing perioperative opioids to teens and young adults?
  • Empagliflozin Trims Liver Fat in Patients With T2D and NAFLD   Dr Kuchay discusses his findings from the E-LIFT study.
  • Why Is Obesity so Challenging? Is it genetic? Is it a simple matter of too much food and not enough exercise? Get to the bottom of this common condition that so many clinicians find extremely vexing.
  • Imaging Found a Focal Liver Lesion--Now What?   Dr David Johnson on how to follow up initial discovery to determine whether what you're dealing with is benign, life-threatening, or something in between.
  • New Guidelines for HCC: The Big Questions Tackled   Dr David Johnson provides clinicians with an overview of the new guidelines from the American Association for the Study of Liver Diseases (AASLD) on hepatocellular carcinoma.
  • Cholecystectomy: Before or After Gastric Bypass? Dr Lowenfels comments on a study comparing complication rates in patients having gallstones removed before and after undergoing a Roux-en-Y gastric bypass procedure.
  • New Guidelines Provide Path Forward for Abnormal Liver Tests Liver chemistry tests can be highly variable. Dr William Balistreri shares the latest data to get you from confusion to the correct diagnosis.
  • Cirrhosis Overview Video   This video discusses the pathophysiology of a cirrhotic liver as well as major complications and clinical signs and symptoms of cirrhosis.
  • Combating Frailty's Fatal Impact in Liver Disease Dr Rowen Zetterman on the various ways in which frailty imperils outcomes in liver disease, and the most useful strategies for addressing them.
  • A Closer Look at Robotic Surgery Cost, Use, and Trends Dr Lowenfels comments on several studies examining costs, outcomes, and recent trends in robotic surgery compared with other procedural approaches.
  • Gastroenterology Data That Primary Care Teams Need to Know   This year's World Congress of Gastroenterology at the American College of Gastroenterology meeting featured several studies whose findings affect primary care. Dr David Johnson highlights the results.
  • Are Older Diabetes Drugs Safe and Effective?   You might have to prescribe older diabetes drugs to some patients so that they will be able to maintain treatment.
  • Top 5 Women's Health Papers From 2017 Dr Peter Kovacs has rounded up what he believes are the most important women's health papers published in 2017.
  • The Year in Gastroenterology: 10 Must-Read Studies New guidelines offered a high-level look at some of the biggest issues in the field. Dr David Johnson chooses the ones most likely to reshape your practice.
  • Novel Therapies for Cholestasis Dr William Balistreri reviews the latest data on treatments for primary sclerosing cholangitis, primary biliary cholangitis, and cholestasis-related pruritus, presented during the Liver Meeting.
  • Ongoing Trials Put Focus Back on Fatty Liver Disease Researchers at this year's Liver Meeting offered promising insights into nonalcoholic steatohepatitis and fatty liver disease. Dr William Balistreri surveys their results.
  • 'Prehab' for Improved Liver Transplantation Outcomes Dr William Balistreri on new data suggesting the value of addressing frailty and malnutrition in patients awaiting liver transplantation.
  • The Day of Cancer Surgery: Any Impact on Outcomes? Dr Lowenfels comments on a study comparing surgery performed on different days of the week and whether it has any relationship to outcomes.